<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35345835</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2589-790X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>CJC open</Title>
          <ISOAbbreviation>CJC Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Case of Systemic Capillary Leak Syndrome with Severe Cardiac Dysfunction after mRNA Vaccination for COVID-19.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjco.2022.03.008</ELocationID>
        <Abstract>
          <AbstractText>A 53-year-old woman with no significant medical history developed cardiogenic shock four days after receiving the second dose of the COVID-19 mRNA vaccine (BNT162b2, Pfizer/BioNtech). The patient required extracorporeal membrane oxygenation and an Impella device. Based on significant hemoconcentration, decreased plasma protein levels, and pathological findings in myocardial specimens, the patient was diagnosed with vaccination-induced fulminant systemic capillary leak syndrome (SCLS) with severe cardiac dysfunction. This Case highlights that SCLS can occur after COVID-19 mRNA vaccination and may be associated with cardiac dysfunction. In patients with cardiogenic shock, hemoconcentration, and hypoalbuminemia after vaccination, SCLS should be considered.</AbstractText>
          <CopyrightInformation>© 2022 Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Araki</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morimoto</LastName>
            <ForeName>Ryota</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ito</LastName>
            <ForeName>Ryota</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mizutani</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kimura</LastName>
            <ForeName>Yuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kazama</LastName>
            <ForeName>Shingo</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oishi</LastName>
            <ForeName>Hideo</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuwayama</LastName>
            <ForeName>Tasuku</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hiraiwa</LastName>
            <ForeName>Hiroaki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kondo</LastName>
            <ForeName>Toru</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okumura</LastName>
            <ForeName>Takahiro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murohara</LastName>
            <ForeName>Toyoaki</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>CJC Open</MedlineTA>
        <NlmUniqueID>101763635</NlmUniqueID>
        <ISSNLinking>2589-790X</ISSNLinking>
      </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>5</Hour>
          <Minute>15</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35345835</ArticleId>
        <ArticleId IdType="pmc">PMC8942571</ArticleId>
        <ArticleId IdType="doi">10.1016/j.cjco.2022.03.008</ArticleId>
        <ArticleId IdType="pii">S2589-790X(22)00056-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abbate A., Gavin J., Madanchi N., et al.  Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol. 2021;340:119–121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8372420</ArticleId>
            <ArticleId IdType="pubmed">34416319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bichon A., Bourenne J., Gainnier M., Carvelli J. Capillary leak syndrome: state of the art in 2021. Rev Med Interne. 2021;42:789–796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34099313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juthier F., Ennezat P.V., Fornes P., et al.  Myocardial involvement in systemic capillary leak syndrome: first demonstration by pathologic findings. Eur Heart J Acute Cardiovasc Care. 2012;1:248–252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3760545</ArticleId>
            <ArticleId IdType="pubmed">24062914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robichaud J., Côté C., Côté F. Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination. CMAJ. 2021;193:E1341–E1344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8432311</ArticleId>
            <ArticleId IdType="pubmed">34362727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi G.J., Baek S.H., Kim J., et al.  Fatal systemic capillary leak syndrome after SARS-COV-2vaccination in patient with multiple myeloma. Emerg Infect Dis. 2021;27 doi: 10.3201/eid2711.211723. Online ahead of print.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2711.211723</ArticleId>
            <ArticleId IdType="pmc">PMC8544977</ArticleId>
            <ArticleId IdType="pubmed">34459725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matheny M., Maleque N., Channell N., et al.  Severe exacerbations of systemic capillary leak syndrome after COVID-19 vaccination: a Case series. Ann Intern Med. 2021;174:1476–1478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8252024</ArticleId>
            <ArticleId IdType="pubmed">34125573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahin U., Muik A., Vogler I., et al.  BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595:572–577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34044428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Then C., Ritzel K., Seibold C., Mann J.F.E., Reincke M. Multiglandular hormone deficiency in a patient with systemic capillary leak syndrome. Case Rep Med. 2015;2015:958283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4313677</ArticleId>
            <ArticleId IdType="pubmed">25685157</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
